12 december 12:30 - 3:30pm ET
12 Dec 12:30 - 1:30pm ET
An Endpoints News team led by managing editor Kyle Blankenship will report on all the top news out of the world’s premier cell and gene therapy science conference held virtually and in Atlanta this year. Blankenship will follow the news coverage with an online panel discussion on what topics grabbed the attention of the experts. And founding editor John Carroll will get that event started with a fireside chat involving a leading industry figure.
Chief Medical Officer, Hematology
Accessible, off-the-shelf CAR T: Are we close?
12 Dec 2:30 - 3:30pm ET
Since their approval five years ago, first-generation, personalized CAR Ts changed how many difficult-to-treat cancers are managed and led to positive patient outcomes. But as demand increases, so do concerns about supply limitations and time to treatment. Join us as we explore a first-of-a-kind initiative to support innovation and bring awareness to clinical trials that may ultimately lead to the availability of an off-the-shelf option for patients unable to wait for a personalized treatment.
Associate member physician, Director of the Lymphoma Program
Colorado Blood Cancer Institute
Rafael G. Amado
Executive Vice President of Research and Development
Chair; Program co-leader, Immuno-Oncology
Department of Blood and Marrow Transplant and Cellular Immunotherapy; Moffitt Cancer Center
Founder & Publisher